A Study to Investigate Pharmacokinetics, Safety, and Tolerability of B2227 Extended-Release Injectable Suspension and Vraylar® in Participants With Schizophrenia
Clinical trial NCT07722728 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07722728
- Sponsor
- Bostal Drug Delivery Co., Ltd
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-01
- Primary completion
- 2027-08-01
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.